Based on the analysis of ICoreConnect Common's profitability, liquidity, and operating efficiency, iCoreConnect Common stock is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January. At this time, ICoreConnect Common's Good Will is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 7.7 M in 2024, whereas Current Deferred Revenue is likely to drop slightly above 113.6 K in 2024. Key indicators impacting ICoreConnect Common's financial strength include:
The financial analysis of ICoreConnect Common is a critical element in measuring its lifeblood. Investors should not minimize ICoreConnect Common's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income
(14.77 Million)
ICoreConnect
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Average Payables
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Sales General And Administrative To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Average Receivables
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Change In Cash
Free Cash Flow
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Change In Working Capital
Change To Account Receivables
Change To Inventory
Stock Based Compensation
Investments
Net Borrowings
Total Cashflows From Investing Activities
Change To Operating Activities
Change To Netincome
Change To Liabilities
Issuance Of Capital Stock
Total Assets
Short Long Term Debt Total
Other Current Liab
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Retained Earnings
Cash
Non Current Assets Total
Cash And Short Term Investments
Net Receivables
Good Will
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Other Stockholder Equity
Total Liab
Total Current Assets
Accumulated Other Comprehensive Income
Short Term Debt
Intangible Assets
Common Stock
Accounts Payable
Non Currrent Assets Other
Other Current Assets
Other Liab
Net Tangible Assets
Long Term Debt
Short Long Term Debt
Property Plant Equipment
Net Invested Capital
Capital Stock
Net Working Capital
Capital Lease Obligations
Property Plant And Equipment Gross
Depreciation And Amortization
Interest Expense
Selling General Administrative
Selling And Marketing Expenses
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Cost Of Revenue
Total Operating Expenses
Income Tax Expense
Income Before Tax
Total Other Income Expense Net
Net Income From Continuing Ops
Net Income Applicable To Common Shares
Net Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past ICoreConnect Common Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ICoreConnect Common's financial statements are interrelated, with each one affecting the others. For example, an increase in ICoreConnect Common's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in ICoreConnect Common's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of iCoreConnect Common stock. Check ICoreConnect Common's Beneish M Score to see the likelihood of ICoreConnect Common's management manipulating its earnings.
ICoreConnect Common Stock Summary
ICoreConnect Common competes with So Young, Evolent Health, MSP Recovery, Healthcare Integrated, and Cogstate. iCoreConnect Inc., a cloud-based software and technology company, provides cloud-based software products for the healthcare sector in the United States. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida. Vemics operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 55 people.
The reason investors look at the income statement is to determine what ICoreConnect Common's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining ICoreConnect Common's current stock value. Our valuation model uses many indicators to compare ICoreConnect Common value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ICoreConnect Common competition to find correlations between indicators driving ICoreConnect Common's intrinsic value. More Info.
iCoreConnect Common stock is rated fourth overall in return on equity category among its peers. It also is rated fourth overall in return on asset category among its peers . At this time, ICoreConnect Common's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value ICoreConnect Common by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
iCoreConnect Common stock Systematic Risk
ICoreConnect Common's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ICoreConnect Common volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on iCoreConnect Common stock correlated with the market. If Beta is less than 0 ICoreConnect Common generally moves in the opposite direction as compared to the market. If ICoreConnect Common Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one iCoreConnect Common stock is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ICoreConnect Common is generally in the same direction as the market. If Beta > 1 ICoreConnect Common moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as ICoreConnect Common is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of ICoreConnect has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if ICoreConnect Common's financials are consistent with your investment objective using the following steps:
Review ICoreConnect Common's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
Study the cash flow inflows and outflows to understand ICoreConnect Common's liquidity and solvency.
Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
Compare ICoreConnect Common's financials to those of its peers to see how it stacks up and identify any potential red flags.
Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if ICoreConnect Common's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.
Today, most investors in ICoreConnect Common Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ICoreConnect Common's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ICoreConnect Common growth as a starting point in their analysis.
ICoreConnect Common December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ICoreConnect Common help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of iCoreConnect Common stock. We use our internally-developed statistical techniques to arrive at the intrinsic value of iCoreConnect Common stock based on widely used predictive technical indicators. In general, we focus on analyzing ICoreConnect Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ICoreConnect Common's daily price indicators and compare them against related drivers.
When running ICoreConnect Common's price analysis, check to measure ICoreConnect Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICoreConnect Common is operating at the current time. Most of ICoreConnect Common's value examination focuses on studying past and present price action to predict the probability of ICoreConnect Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICoreConnect Common's price. Additionally, you may evaluate how the addition of ICoreConnect Common to your portfolios can decrease your overall portfolio volatility.